RxDoctor Payments Data

Yuli McCann, MD

Rheumatology · Seattle, WANPI 1619169729

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 157 rheumatology providers in Washington.

See all rheumatology providers in Washington

Medicare billing

Part B allowed, 2024
$782,489
Medicare patients
329
Services billed
31,769

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept64$551,688
Humira(Cf) PenAdalimumab24$164,228
XeljanzTofacitinib Citrate15$85,249
RinvoqUpadacitinib13$81,313
Orencia ClickjectAbatacept12$67,246
MethotrexateMethotrexate Sodium253$7,067
Hydroxychloroquine Sulfate80$3,439
Leflunomide37$1,324
Colchicine17$1,186
Sulfasalazine DrSulfasalazine16$917
Azathioprine15$871
Sulfasalazine24$831
Allopurinol78$789
Gabapentin34$746
Prednisone100$661

Paid to pharmacies, not to this prescriber.

Other rheumatology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →